NO993066L - Ny behandling for leddinflammasjon - Google Patents

Ny behandling for leddinflammasjon

Info

Publication number
NO993066L
NO993066L NO993066A NO993066A NO993066L NO 993066 L NO993066 L NO 993066L NO 993066 A NO993066 A NO 993066A NO 993066 A NO993066 A NO 993066A NO 993066 L NO993066 L NO 993066L
Authority
NO
Norway
Prior art keywords
joint inflammation
new treatment
treatment
subtance
glucocorticoid
Prior art date
Application number
NO993066A
Other languages
English (en)
Other versions
NO993066D0 (no
Inventor
Roger Hollgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO993066D0 publication Critical patent/NO993066D0/no
Publication of NO993066L publication Critical patent/NO993066L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Anvendelse av en glukokortikoid subtans som har en minimal systemisk effekt, i frem- stillingen av et legemiddel for oral eller rektal administrasjon for ikke-topisk bruk i behandlingen av leddinflammasjon.
NO993066A 1996-12-20 1999-06-21 Ny behandling for leddinflammasjon NO993066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation

Publications (2)

Publication Number Publication Date
NO993066D0 NO993066D0 (no) 1999-06-21
NO993066L true NO993066L (no) 1999-06-21

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993066A NO993066L (no) 1996-12-20 1999-06-21 Ny behandling for leddinflammasjon

Country Status (20)

Country Link
US (1) US6432937B1 (no)
EP (1) EP0957922A1 (no)
JP (1) JP2001507024A (no)
KR (1) KR20000069594A (no)
AU (1) AU5502598A (no)
BR (1) BR9713975A (no)
CA (1) CA2274769A1 (no)
CZ (1) CZ219399A3 (no)
EE (1) EE9900258A (no)
HU (1) HUP0000397A3 (no)
ID (1) ID21763A (no)
IL (1) IL130485A0 (no)
IS (1) IS5056A (no)
NO (1) NO993066L (no)
NZ (1) NZ336025A (no)
PL (1) PL334012A1 (no)
SE (1) SE9604751D0 (no)
SK (1) SK82699A3 (no)
TR (1) TR199901413T2 (no)
WO (1) WO1998027987A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140097446A (ko) 2006-11-20 2014-08-06 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 통증 및 소양증 치료용 방법, 조성물 및 키트
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
JP6205133B2 (ja) 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP3970723A1 (en) 2011-02-18 2022-03-23 Asana BioSciences, LLC Aminoindane compounds for use in treating urological pain
JP6495654B2 (ja) 2011-10-24 2019-04-03 アサナ バイオサイエンシズ，リミティド ライアビリティ カンパニー シクロヘキシルアミン類
WO2015095128A1 (en) 2013-12-16 2015-06-25 Asana Biosciences, Llc P2x3 and/or p2x2/3 compounds and methods
CN108348774A (zh) 2015-08-03 2018-07-31 哈佛大学校长及研究员协会 带电离子通道阻断剂及其应用
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
MX2019003710A (es) 2016-09-30 2019-06-24 Asana Biosciences Llc Compuestos y metodos de p2x3 y/o p2x2/3.
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
MA55320A (fr) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueurs de canaux ioniques substitués par un ester et méthodes d'utilisation
MX2021010870A (es) 2019-03-11 2022-01-19 Nocion Therapeutics Inc Bloqueadores de canales ionicos cargados y metodos de uso.
CN113811305A (zh) 2019-03-11 2021-12-17 诺西恩医疗公司 带电的离子通道阻滞剂及其使用方法
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023500890A (ja) 2019-11-06 2023-01-11 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
WO2021091585A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023517604A (ja) 2020-03-11 2023-04-26 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
NO993066D0 (no) 1999-06-21
KR20000069594A (ko) 2000-11-25
SE9604751D0 (sv) 1996-12-20
IL130485A0 (en) 2000-06-01
CA2274769A1 (en) 1998-07-02
IS5056A (is) 1999-05-27
US6432937B1 (en) 2002-08-13
HUP0000397A2 (hu) 2000-10-28
ID21763A (id) 1999-07-22
AU5502598A (en) 1998-07-17
EE9900258A (et) 1999-12-15
EP0957922A1 (en) 1999-11-24
PL334012A1 (en) 2000-01-31
WO1998027987A1 (en) 1998-07-02
BR9713975A (pt) 2000-04-11
TR199901413T2 (xx) 1999-08-23
SK82699A3 (en) 2000-02-14
HUP0000397A3 (en) 2001-01-29
JP2001507024A (ja) 2001-05-29
NZ336025A (en) 2001-02-23
CZ219399A3 (cs) 1999-09-15

Similar Documents

Publication Publication Date Title
NO993066L (no) Ny behandling for leddinflammasjon
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
FI964249A (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
DE69710065T2 (de) Androsten-derivate
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
NZ505073A (en) Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant, useful for treating allergic, inflammatory and intestinal diseases
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
NO20004419L (no) Ny anvendelse
DE69932510D1 (de) Vaskularisierungsinhibitoren
RS49701B (sr) Vodene suspenzije za nazalnu primenu
FI972308A (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
EE04954B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DK1189595T3 (da) Ophthalmiske sammensætninger i form af vandige geler
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ATE28188T1 (de) Antikonvulsive mittel.
ES2131482A1 (es) Formulacion acuosa de bambuterol.
AU580890B2 (en) P-acylaminobenzamides
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application